Search results
Postpartum Psychosis Is Rare (and Can Be Scary), but It's Treatable—Here Are Warning Signs To Watch...
Well and Good· 2 days ago“Postpartum is a time of heightened risk for many types of mental health issues, including...
Why Does My Ear Hurt? ENT Specialists Break Down Common Culprits
PopSugar· 4 days agoIt's easy to take your ability to blissfully sail through life without ear pain for granted — until...
Carbon Biosciences Announces New Appointments to Board of Directors and Scientific Advisory Board
WKRN Nashville· 5 days ago- Carol Ann Satler, MD, PhD, FACC, FAHA, FAAP joins the Board of Directors, adding key clinical experience to guide ongoing nonclinical development in cardiac ...
Studies Prove Group Walking Is Even Better at Boosting Weight Loss — How Your Health Can Benefit
First for Women via Yahoo News· 3 days agoHe cites Marisa Franco, PhD’s book Platonic, on the science of social attachment, which emphasizes...
American College of Surgeons Honors First Responde | Newswise
Newswise· 4 days agoTurner, MD, MBA, FACS, called on everyone to learn bleeding control techniques and other life-saving...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 ...
Cedars-Sinai Names Inaugural Vice Dean of Graduate | Newswise
Newswise· 5 days agoLOS ANGELES (May 22, 2024) -- Joshua I. Goldhaber, MD, a nationally regarded physician-scientist who has devoted much of his career to physician training and mentoring, has ...
How to Treat AUD in Patients With Liver Disease
Medscape· 7 days ago...including an increase in global alcohol consumption, increase in alcohol consumption and binge drinking among women, social media and increased...
The FLCCC Alliance International Fellowship Program Announces 14 New Senior Fellows Across 11...
WFRV 5 Green Bay· 3 days agoThe FLCCC Alliance today announced the addition of 14 new senior fellows to its international fellowship program. The FLCCC fellowship program's mission ...
Rila Therapeutics Announces Dosing of First Cohort in Phase 1 Clinical Trial of RLA-23174, a...
The Yuma Sun· 6 days agoRLA-23174 is a first-in-class small molecule allosteric inhibitor of HIPK2 which inhibits TGF-β signaling to address FSGS and other fibrotic diseases. RLA-23174 is a new small molecule allosteric ...
